Latest News
- The Antibody Cocktail, RONAPREVE for Intravenous Infusion Set Receives the World’s First Regulatory Approval from MHLW for COVID-19
- Chugai Released Short Film Featuring Mayu Hotta and Nami Kishida “I Wanted to Understand What I Didn't Understand When I Took That Child on a Trip” -NMOSD Disease Awareness Short Film-
- Chugai and Alebund Enter into Option and License Agreement for EOS789 under Development for Hyperphosphatemia
More News Articles
- The Antibody Cocktail, RONAPREVE for Intravenous Infusion Set Receives the World’s First Regulatory Approval from MHLW for COVID-19
- Chugai Released Short Film Featuring Mayu Hotta and Nami Kishida “I Wanted to Understand What I Didn't Understand When I Took That Child on a Trip” -NMOSD Disease Awareness Short Film-
- Chugai and Alebund Enter into Option and License Agreement for EOS789 under Development for Hyperphosphatemia
- Disposal of Vaccines for Workplace Vaccination
- Chugai Files for Additional Indication of Tecentriq for the Adjuvant Treatment of Non-small Cell Lung Cancer
- Chugai Files New Drug Application in Japan for Antibody Cocktail Casirivimab and Imdevimab for the Treatment of COVID-19
- Chugai’s Enspryng (Satralizumab) Approved by European Commission as First At-home Subcutaneous Treatment for Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Chugai and ALBERT Jointly Develop Data Scientist Training Program for Pharmaceutical Industry - Promotion of DX through acquisition of data utilization skills including pharmaceutical-specific elements -
- Immunosuppressant CellCept, Approved for Additional Indication of Prevention of Graft-Versus-Host Disease in Hematopoietic Stem-Cell Transplantation
- Genentech Announces FDA Emergency Use Authorization for Chugai’s Actemra for Hospitalized Patients with COVID-19
- Chugai Obtains Regulatory Approval for Evrysdi for the Treatment of Spinal Muscular Atrophy
- Chugai Obtains Regulatory Approval for FoundationOne CDx Cancer Genomic Profile to be Used as Companion Diagnostic for MSI-High Tumors
- Chugai Files New Drug Application in Japan for Faricimab, the First Bispecific Antibody in Ophthalmology for Diabetic Macular Edema and Neovascular Age-related Macular Degeneration
- Chugai Selected as Digital Transformation Stock (DX Stock) 2021
- Chugai Introduces First Cryo-electron Microscopy System in Pharmaceutical Industry in Japan
Company Events
Fruits Day
2021 Kaizen and 2020 Christmas Party
December 11, 2020
7th Antibody Symposium
November 23, 2020
8th anniversary online party
August 28, 2020
Celebrating Project Achievement
January 09, 2020
2019 Xmas Party
December 20, 2019
2019 Kaizen Presentation
December 19, 2019
7th Anniversary Party
July 26, 2019
1sᴛ Student Visit
February 20, 2019
6th Antibody Symposium in Biopolis, Singapore
September 23, 2019
5th Antibody Symposium in Biopolis, Singapore
March 5-6, 2018
One north Festival
August, 2017
CPR’s 5th Anniversary Party
November 14, 2016
BioPharma Asia Convention 2014
March 10-13, 2014
Biopolis 10th Anniversary Carnival
October 18, 2013
CPR’s 1st Anniversary Party
June 27, 2013
BioPharma Asia Convention 2013
March 19, 2013
4th Antibody Symposium in Biopolis, Singapore
November 14, 2016
3rd Antibody Symposium in Biopolis, Singapore
January 14, 2015
2nd Antibody Symposium in Biopolis, Singapore
September 10, 2013
1st Antibody Symposium in Biopolis, Singapore
September 17, 2012
Official Opening Ceremony
July 13, 2012